European Lithium Ltd - Update on SPP and Empire Mandate
RNS Number : 2201B
European Lithium Limited
06 October 2020

European Lithium Ltd

("European Lithium", "EUR" or "the Company")


European Lithium Limited (ASX:EUR)(FRA: PF8)(VSE: ELI)(AQSE: EUR) (the Company) is conducting a share purchase plan (SPP) which offers all existing eligible shareholders the opportunity to subscribe for new shares at $0.0475 per Share  up to a maximum of 666,667 shares (maximum of $30,000). Funds raised under the SPP will be used primarily towards exploration on E47/4144.


The Company is in the process of finalising the offer booklet for the SPP. The Company estimates that the offer booklet will be dispatched to eligible shareholders on 8 October 2020 and that the SPP offer will open on the same day. A revised indicative timetable for the SPP is set out in Annexure.


To apply for Shares under the SPP, shareholders should read the offer booklet and follow the instructions on the personalised application form accompanying the offer booklet. 

Beneficial holders whose shares are held through a custodian and who wish to participate in the SPP should contact their custodian.


EUR reserves its right to place any shortfall under the SPP at a price not less than the Issue Price in accordance with its share issue capacity under the Listing Rules.  For details on the shortfall, please contact Empire Capital on +61 8 9388 9230 or between 8.30am and 5.30pm (WST)

Corporate Advisor Mandate with Empire Capital

The Company is pleased to advise that it has executed a mandate with Empire Capital Pty Ltd (Empire), a boutique corporate advisory and investment firm focused on investments in the Australian resources and oil and gas sectors, to provide corporate advisor services to EUR (Mandate).


The Mandate services comprise two major components:

a)  Corporate advisor and lead manager services to advise and lead an acquisition transaction involving a merger or exchange offer, acquisition of assets or equity interests, or similar transaction involving all or a majority of the Company's business, assets, or equity interests (M&A Transaction); and

b)  lead and manage a financing transaction by way of an equity raise, debt facility and offtake agreement and/or other debt, or structured finance for parties through whom Empire obtains funding proposals in connection with the M&A Transaction for a minimum of A$10M and a maximum of A$20M (Financing Transaction).


Empire's services to the Company include but are not limited to:

a)  identifying and qualifying potential M&A targets;

b)  preparing information package or confidential information memorandum;

c)  advising the Company as to the transaction strategy etc;

d)  introducing and participating in confidential transaction discussions with potential counterparties introduced by Empire;

e)  assisting and participating in any due diligence exercise;

f)    advising the Company as to the structure and form of the transaction; and

g)  assisting, as necessary, in the preparation of contracts, documents, approvals and related matters necessary to close the transaction.


The Company confirms that as of today, no target has been identified for a M&A Transaction and no proposal has been initiated for a Financing Transaction. Announcements will be made in accordance with ASX Listing Rules as and when they are required for such transactions.


Under the terms of the Mandate:

a)  The Mandate commences on 1 October 2020 and will continue for 12 months unless terminated earlier in accordance with its terms (the Company may terminate this Agreement at any time, with or without cause, on written notice to Empire);

b)  EUR will issue Empire 1 million fully paid ordinary shares upon the execution of the Mandate.  These shares will be issued without shareholder approval and using the Company's existing capacity under Listing Rule 7.1;

c)  EUR will pay Empire a monthly fee of $5,000 (exclusive of GST) to be paid, subject to the Listing Rules, in equity at an issue price equal to a 15% discount to the 10-day VWAP, payable upon the Company completing a $2 million placement and $2 million share purchase plan (refer to the ASX announcement on 23 September 2020);

d)  Subject to the Listing Rules, Empire will be issued 2.5 million fully paid ordinary shares upon the execution of a binding heads of agreement (HoA Shares) for a M&A Transaction and Financing Transaction; and

e)  Upon entering into definitive transaction documents and subject to the Listing Rules, Empire will be issued Shares to the value of 3% of the total value of the M&A Transaction and 6% of the Financing Transaction; with an issue price at a 15% discount to the 10-day VWAP less the 2.5 million HoA Shares under paragraph d) above.



Tony Sage

Non-Executive Chairman

European Lithium Limited


- END -



Visit the Company's website to find out more about the advanced Wolfsberg Lithium Project located in Austria.

For further information please contact:

European Lithium Ltd

+61 861 819 792

Tony Sage



NEX Corporate Adviser

+44 207 220 1666

James Joyce


James Sinclair-Ford








Annexure "A"

Share Purchase Plan Timetable



Record date for eligibility to participate in the SPP

5.00pm (AWST), 22 September 2020

Dispatch of SPP offer Documents and SPP offer open

8 October 2020

SPP closing Date

3 November 2020

Announcement of SPP Participation Results

6 November 2020

Issue of new shares under the SPP

12 November 2020


The timetable is indicative only and remains subject to change at EUR's discretion, subject to compliance with applicable laws and the ASX Listing Rules.


This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.